Genmab hosted a 2017 R&D Update on December 11 in Atlanta, Georgia. The meeting included the presentation of daratumumab data presented at the 2017 American Society of Hematology Annual Meeting (December 9-12) as well as a discussion of Genmab's product pipeline, 2017 progress and key goals for 2018.To listen to the archived webcast, click here. To download the presentation, click here. This meeting was not an official program of the ASH Annual meeting.